Smith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)
Smith & Nephew plc Reports Q3 2026 Revenue of $1,551 million and Lowers Full-Year Guidance
Smith & Nephew plc Reports Q3 2026 Revenue of $1,551 million and Revises Full-Year Guidance
Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call Transcript
Smith & Nephew plc (SNN) Q3 2026 Sales/ Trading Statement Call - Slideshow
Smith+Nephew Q3 Revenue Rises 3.4% YoY To $1.551B; $250M Of $500M Buyback Completed; Confirms Johnson & Johnson Talks Ended, Still Exploring Orthopaedics Strategic Options
Smith & Nephew (LSE:SN.) Stock May Be 34% Below Fair Value As Merger Talks Collapse
Update: Market Chatter: Johnson & Johnson Orthopedics, Smith & Nephew Merger Collapsed Over Leadership Dispute
Smith & Nephew plc Announces Sterling Dividend Amount of 11.65 Pence per Share
Smith & Nephew (NYSE:SNN) Looks Like a Decent Value Stock
UBS sees attractive risk/reward in three European medtech into Q3 results
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
Smith & Nephew Launches CartiHeal Cartilage Repair Implant in Europe
Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
Smith+Nephew Receives 510(k) Clearance From FDA And Completes First Surgical Cases With LANDMARK Total Knee System
S.N. Nuclearelectrica (BVB:SNN) Stock Gets Fair Value Boost As Analysts Rework Growth Assumptions
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.